Q3 2024 revenue rose 6.3% year-over-year to $269.2 million, but net loss widened to $24.9 million. Substantial doubt remains about Exela's ability to continue as a going concern, and shares were delisted from Nasdaq in November 2024.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.